52.69

0.50% 0.26

After Hours: 52.69

Bio Techne Corp (TECH)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Bio Techne Corp stock is traded at $52.69, with a volume of 1.60M. It is up +0.50% in the last 24 hours and down -8.95% over the past month. Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Previous Close:

$52.43

Open:

$52.69

24h Volume:

1.60M

Relative Volume:

0.70

Market Cap:

$8.24B

Revenue:

$1.22B

Net Income/Loss:

$81.07M

P/E Ratio:

102.49

EPS:

0.5141

Net Cash Flow:

$223.02M

1W Performance:

+3.70%

1M Performance:

-8.95%

6M Performance:

+4.38%

1Y Performance:

-12.15%

1-Day Range:

$52.02

$53.23

1-Week Range:

$50.02

$53.53

52-Week Range:

$46.01

$72.16

Bio Techne Corp Stock (TECH) Company Profile

Name

Bio Techne Corp

Sector

Healthcare (1114)

Industry

Biotechnology (623)

Phone

612-379-8854

Address

614 MCKINLEY PL N E, MINNEAPOLIS, MN

Employee

3,100

Twitter

@biotechne

Next Earnings Date

2024-10-30

Latest SEC Filings

TECH's Discussions on Twitter

Compare TECH vs VRTX, REGN, ALNY, ARGX, INSM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TECH Bio Techne Corp	52.69	8.20B	1.22B	81.07M	223.02M	0.5141
VRTX Vertex Pharmaceuticals Inc	454.97	113.96B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	749.47	78.41B	14.34B	4.50B	3.77B	41.56
ALNY Alnylam Pharmaceuticals Inc	328.70	40.85B	3.71B	313.75M	465.38M	2.2571
ARGX Argen X Se Adr	697.05	42.05B	4.16B	1.29B	734.26M	19.58
INSM Insmed Inc	148.31	29.99B	606.42M	-1.28B	-997.58M	-6.403

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-03-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Aug-21-25	Upgrade	Citigroup	Neutral → Buy
Jul-22-25	Resumed	Stephens	Overweight
Jul-09-25	Initiated	TD Cowen	Buy
May-30-25	Initiated	Wells Fargo	Overweight
Apr-09-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Mar-18-25	Initiated	Evercore ISI	Outperform
Feb-19-25	Downgrade	Robert W. Baird	Outperform → Neutral
May-22-24	Downgrade	Citigroup	Buy → Neutral
Feb-08-24	Initiated	Scotiabank	Sector Outperform
Feb-02-24	Downgrade	Stifel	Buy → Hold
Dec-07-23	Initiated	UBS	Buy
Aug-28-23	Initiated	William Blair	Outperform
Jan-10-23	Upgrade	Wells Fargo	Underweight → Equal Weight
Dec-14-22	Initiated	Deutsche Bank	Buy
Dec-12-22	Upgrade	Citigroup	Neutral → Buy
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform
Aug-25-22	Initiated	Credit Suisse	Outperform
Apr-25-22	Downgrade	Wells Fargo	Equal Weight → Underweight
Sep-15-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-08-21	Upgrade	Stephens	Equal-Weight → Overweight
Feb-23-21	Upgrade	Stifel	Hold → Buy
Jan-25-21	Reiterated	The Benchmark Company	Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-30-20	Initiated	Atlantic Equities	Overweight
Jul-15-20	Downgrade	Stephens	Overweight → Equal-Weight
May-27-20	Downgrade	Stifel	Buy → Hold
May-14-20	Initiated	The Benchmark Company	Buy
Jan-08-20	Resumed	Stephens	Overweight
Jan-08-20	Initiated	Wells Fargo	Equal Weight
Jan-07-20	Initiated	Citigroup	Neutral
Nov-15-19	Initiated	Stifel	Buy
Jul-02-19	Upgrade	Janney	Neutral → Buy
Jan-14-19	Upgrade	Stephens	Equal-Weight → Overweight
Oct-31-18	Downgrade	Craig Hallum	Buy → Hold
Oct-17-18	Initiated	Goldman	Neutral
Jun-15-18	Initiated	Argus	Buy
Jul-13-17	Initiated	Wells Fargo	Market Perform
Feb-09-17	Initiated	Citigroup	Buy
Jan-18-17	Initiated	Deutsche Bank	Buy
Nov-10-16	Resumed	Leerink Partners	Outperform
Jan-21-15	Reiterated	Robert W. Baird	Outperform
Sep-20-13	Upgrade	Robert W. Baird	Neutral → Outperform

View All

Bio Techne Corp Stock (TECH) Latest News

Mar 25, 2026

Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite - The AI Journal

Mar 25, 2026

Tudor Investment Corp ET AL Purchases Shares of 242,016 Bio-Techne Corp $TECH - MarketBeat

Mar 22, 2026

JPMorgan Chase Sells Stake in Bio-Techne Corp - National Today

Mar 22, 2026

JPMorgan Chase & Co. Sells 633,738 Shares of Bio-Techne Corp $TECH - MarketBeat

Mar 22, 2026

Mar 21, 2026

38,300 Shares in Bio-Techne Corp $TECH Purchased by Covea Finance - MarketBeat

Mar 21, 2026

After a Long Reset Period, Life Science Stocks Look Set to Rebound - Morningstar

Mar 21, 2026

Mar 20, 2026

How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks - Yahoo Finance

Mar 20, 2026

ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape - GlobeNewswire Inc.

Mar 20, 2026

TECH SEC FilingsBio-Techne Corp 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 20, 2026

Bio-Techne Corp (NASDAQ:TECH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 20, 2026

Mar 19, 2026

Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch

Mar 19, 2026

Mar 18, 2026

Bio-Techne Corp. stock underperforms Monday when compared to competitors - MSN

Mar 18, 2026

Mar 17, 2026

Should You Continue to Hold Bio-Techne Stock in Your Portfolio? - Yahoo Finance

Mar 17, 2026

Risk Check: Will Bio Techne Corporation outperform the market in YEAR2026 Levels & Fast Moving Market Watchlists - baoquankhu1.vn

Mar 17, 2026

Bio-Techne stock falls on AI software concerns, TD Cowen sees buy opportunity - Investing.com

Mar 17, 2026

Mairs & Power Inc. Has $156.18 Million Stock Position in Bio-Techne Corp $TECH - MarketBeat

Mar 17, 2026

Mar 16, 2026

April McClain Delaney makes multiple stock transactions in Bio-Techne, BJ’s Wholesale, and C.H Robinson - Investing.com Nigeria

Mar 16, 2026

Trading the Move, Not the Narrative: (TECH) Edition - Stock Traders Daily

Mar 16, 2026

Hollow Brook Wealth Management Increases Stake in Bio-Techne Corp - National Today

Mar 16, 2026